The global biotechnology reagents & kits market size is calculated at USD 574.41 billion in 2025 and is forecasted to reach around USD 1,454.92 billion by 2034, accelerating at a solid CAGR of 10.89% from 2025 to 2034. The North America market size surpassed USD 20.70 billion in 2024 and is expanding at a CAGR of 11.02% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biotechnology Reagents & Kits Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biotechnology Reagents & Kits Market, by Kits Type
8.1.1. Amplifications Kits
8.1.1.1. Market Revenue and Forecast
8.1.2. Isolation Kits
8.1.2.1. Market Revenue and Forecast
8.1.3. Purification Kits
8.1.3.1. Market Revenue and Forecast
8.1.4. Detection Kits
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Biotechnology Reagents & Kits Market, by Micro-Organisms Type
9.1.1. Virus
9.1.1.1. Market Revenue and Forecast
9.1.2. Bacteria
9.1.2.1. Market Revenue and Forecast
9.1.3. Fungi
9.1.3.1. Market Revenue and Forecast
9.1.4. Parasites
9.1.4.1. Market Revenue and Forecast
10.1. Biotechnology Reagents & Kits Market, by Technology Type
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast
10.1.2. Cell Culture
10.1.2.1. Market Revenue and Forecast
10.1.3. LAMP
10.1.3.1. Market Revenue and Forecast
10.1.4. Chromatography
10.1.4.1. Market Revenue and Forecast
10.1.5. Sequencing
10.1.5.1. Market Revenue and Forecast
10.1.6. Flow Cytometry
10.1.6.1. Market Revenue and Forecast
10.1.7. Electrophoresis
10.1.7.1. Market Revenue and Forecast
10.1.8. Others
10.1.8.1. Market Revenue and Forecast
11.1. Biotechnology Reagents & Kits Market, by Tested Parameters Type
11.1.1. RNA
11.1.1.1. Market Revenue and Forecast
11.1.2. DNA
11.1.2.1. Market Revenue and Forecast
11.1.3. Enzymes
11.1.3.1. Market Revenue and Forecast
11.1.4. Proteins
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. Biotechnology Reagents & Kits Market, by End User
12.1.1. Healthcare
12.1.1.1. Market Revenue and Forecast
12.1.2. Food & Agriculture
12.1.2.1. Market Revenue and Forecast
12.1.3. Industrial Processing
12.1.3.1. Market Revenue and Forecast
12.1.4. Natural Resource & Environment
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Kits
13.1.2. Market Revenue and Forecast, by Micro-Organisms
13.1.3. Market Revenue and Forecast, by Technology
13.1.4. Market Revenue and Forecast, by Tested Parameters
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Kits
13.1.6.2. Market Revenue and Forecast, by Micro-Organisms
13.1.6.3. Market Revenue and Forecast, by Technology
13.1.6.4. Market Revenue and Forecast, by Tested Parameters
13.1.7. Market Revenue and Forecast, by End User
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Kits
13.1.8.2. Market Revenue and Forecast, by Micro-Organisms
13.1.8.3. Market Revenue and Forecast, by Technology
13.1.8.4. Market Revenue and Forecast, by Tested Parameters
13.1.8.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Kits
13.2.2. Market Revenue and Forecast, by Micro-Organisms
13.2.3. Market Revenue and Forecast, by Technology
13.2.4. Market Revenue and Forecast, by Tested Parameters
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Kits
13.2.6.2. Market Revenue and Forecast, by Micro-Organisms
13.2.6.3. Market Revenue and Forecast, by Technology
13.2.7. Market Revenue and Forecast, by Tested Parameters
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Kits
13.2.9.2. Market Revenue and Forecast, by Micro-Organisms
13.2.9.3. Market Revenue and Forecast, by Technology
13.2.10. Market Revenue and Forecast, by Tested Parameters
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Kits
13.2.12.2. Market Revenue and Forecast, by Micro-Organisms
13.2.12.3. Market Revenue and Forecast, by Technology
13.2.12.4. Market Revenue and Forecast, by Tested Parameters
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Kits
13.2.14.2. Market Revenue and Forecast, by Micro-Organisms
13.2.14.3. Market Revenue and Forecast, by Technology
13.2.14.4. Market Revenue and Forecast, by Tested Parameters
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Kits
13.3.2. Market Revenue and Forecast, by Micro-Organisms
13.3.3. Market Revenue and Forecast, by Technology
13.3.4. Market Revenue and Forecast, by Tested Parameters
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Kits
13.3.6.2. Market Revenue and Forecast, by Micro-Organisms
13.3.6.3. Market Revenue and Forecast, by Technology
13.3.6.4. Market Revenue and Forecast, by Tested Parameters
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Kits
13.3.8.2. Market Revenue and Forecast, by Micro-Organisms
13.3.8.3. Market Revenue and Forecast, by Technology
13.3.8.4. Market Revenue and Forecast, by Tested Parameters
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Kits
13.3.10.2. Market Revenue and Forecast, by Micro-Organisms
13.3.10.3. Market Revenue and Forecast, by Technology
13.3.10.4. Market Revenue and Forecast, by Tested Parameters
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Kits
13.3.11.2. Market Revenue and Forecast, by Micro-Organisms
13.3.11.3. Market Revenue and Forecast, by Technology
13.3.11.4. Market Revenue and Forecast, by Tested Parameters
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Kits
13.4.2. Market Revenue and Forecast, by Micro-Organisms
13.4.3. Market Revenue and Forecast, by Technology
13.4.4. Market Revenue and Forecast, by Tested Parameters
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Kits
13.4.6.2. Market Revenue and Forecast, by Micro-Organisms
13.4.6.3. Market Revenue and Forecast, by Technology
13.4.6.4. Market Revenue and Forecast, by Tested Parameters
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Kits
13.4.8.2. Market Revenue and Forecast, by Micro-Organisms
13.4.8.3. Market Revenue and Forecast, by Technology
13.4.8.4. Market Revenue and Forecast, by Tested Parameters
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Kits
13.4.10.2. Market Revenue and Forecast, by Micro-Organisms
13.4.10.3. Market Revenue and Forecast, by Technology
13.4.10.4. Market Revenue and Forecast, by Tested Parameters
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Kits
13.4.11.2. Market Revenue and Forecast, by Micro-Organisms
13.4.11.3. Market Revenue and Forecast, by Technology
13.4.11.4. Market Revenue and Forecast, by Tested Parameters
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Kits
13.5.2. Market Revenue and Forecast, by Micro-Organisms
13.5.3. Market Revenue and Forecast, by Technology
13.5.4. Market Revenue and Forecast, by Tested Parameters
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Kits
13.5.6.2. Market Revenue and Forecast, by Micro-Organisms
13.5.6.3. Market Revenue and Forecast, by Technology
13.5.6.4. Market Revenue and Forecast, by Tested Parameters
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Kits
13.5.8.2. Market Revenue and Forecast, by Micro-Organisms
13.5.8.3. Market Revenue and Forecast, by Technology
13.5.8.4. Market Revenue and Forecast, by Tested Parameters
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Danaher Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Becton Dickinson & Company
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio-Rad Laboratories
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. GE Healthcare
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Siemens Healthcare
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merck KGaA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Thermo Fisher Scientific Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Waters Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample